Brief Interventions to Reduce Ecstasy Use: A Multi-Site Randomized Controlled Trial

Behavior Therapy

Volumn 45, Issue 6, 2014, Pages 745-759

  Norberg, Melissa M ^a,b,c   Hides, Leanne ^d   Olivier, Jake ^e   Khawar, Laila ^c   McKetin, Rebecca ^c,f   Copeland, Jan ^b  

^a MACQUARIE UNIVERSITY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

Ecstacy; Education; MDMA; Motivational enhancement therapy; Randomized controlled trial

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ARTICLE; BEHAVIOR CONTROL; BEHAVIOR THERAPY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DEPENDENCE; DRUG USE; HEALTH EDUCATION; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MOTIVATIONAL ENHANCEMENT THERAPY; PATIENT SATISFACTION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT DURATION; TREATMENT RESPONSE; FEMALE; INTERNET; MALE; MOTIVATION; MOTIVATIONAL INTERVIEWING; PSYCHOLOGICAL RATING SCALE; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; YOUNG ADULT;

FEMALE; HEALTH EDUCATION; HUMANS; INTERNET; MALE; MOTIVATION; MOTIVATIONAL INTERVIEWING; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PATIENT SATISFACTION; PSYCHIATRIC STATUS RATING SCALES; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84908218314     PISSN: 00057894     EISSN: 18781888     Source Type: Journal    
DOI: 10.1016/j.beth.2014.05.006     Document Type: Article

References (67)

1. Annis H.M., Martin G. Inventory of Drug-Taking Situations 1985, Addiction Research Foundation, Toronto.
2. Apodaca T.R., Longabaugh R. Mechanisms of change in motivational interviewing: A review and preliminary evaluation of the evidence. Addiction 2009, 104:705-715.
3. Attkisson C.C., Greenfield T.K. The UCSF client satisfaction scales: I. The Client Satisfaction Questionnaire-8. The use of psychological testing for treatment planning and outcomes assessment 2004, 799-811. Lawrence Erlbaum Associates, Mahwah, NJ. 3rd ed. M. Maruish (Ed.).
4. Australian Institute of Health and Welfare 2010 National Drug Strategy Household Survey Report 2011, AIHW, Canberra.
5. Barnett A.G., van der Pols J.C., Dobson A.J. Regression to the mean: What it is and how to deal with it. International Journal of Epidemiology 2005, 34:215-220.
6. Bond F.W., Hayes S.C., Baer R.A., Carpenter K.M., Guenole N., Orcutt H.K., . . ., Zettle R.D. Preliminary psychometric properties of the Acceptance and Action Questionnaire-II: A revised measure of psychological inflexibility and experiential avoidance. Behavior Therapy 2011, 42:676-688. 10.1016/j.beth.2011.03.007.
7. Bruno R., Matthews A.J., Topp L., Degenhardt L., Gomez R., Dunn M. Can the Severity of Dependence Scale be usefully applied to ecstasy?. Neuropsychobiology 2009, 60:137-147. 10.1159/000253550.
8. Businelle M.S., Kendzor D.E., Rash C.J., Patterson S., Copeland A.L. The development and validation of the methylenedioxymethamphetamine (MDMA) beliefs questionnaire (MDMA-BQ) in college students. Addiction Research and Theory 2009, 17:432-445. 10.1080/16066350801902442.
9. Carlson R.G., Falck R.S., McCaughan J.A., Siegal H.A. MDMA/Ecstasy use among young people in Ohio: Perceived risk and barriers to intervention. Journal of Psychoactive Drugs 2004, 36:181-189. 10.1080/02791072.2004.10399728.
10. Carroll K.M., Ball S.A., Nich C., Martino S., Frankforter T.L., Farentinos C., . . ., Woody G.E. Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: A multisite effectiveness study. Drug and Alcohol Dependence 2006, 81:301-312.
11. Cumming G. ESCI (Exploratory Software for Confidence Intervals) - Software from The New Statistics: Estimation for Better Research Retrieved on 14/FEB/2014 from. http://www.latrobe.edu.au/psy/research/cognitive-and-developmental-psychology/esci.
12. Cumming G. The new statistics: Why and how. Psychological Science 2013, 25:7-29. 10.1177/0956797613504966.
13. Davis K.E., Devitt T., O'Neill S.O., Kaiser S.M., Mueser K.T. Targeting consumers in the early stages of substance use treatment: A pilot study. Psychiatric Rehabilitation Journal 2014, 37:37-42.
14. de Win M.M., Jager G., Booij J., Reneman L., Schilt T., Lavini C., . . ., van den Brink W. Sustained effects of ecstasy on the human brain: A prospective neuroimaging study in novel users. Brain 2008, 131:2936-2945. 10.1093/brain/awn255.
15. Devilly G.J., Borkovec T.D. Psychometric properties of the credibility/expectancy questionnaire. Journal of Behavior Therapy and Experimental Psychiatry 2000, 31:73-86. 10.1016/s0005-7916(00)00012-4.
16. Di lorio C.R., Watkins T.J., Dietrich M.S., Cao A., Blackford J.U., Rogers B., . . ., Cowan R.L. Evidence for chronically altered serotonin function in the cerebral cortex of female 3, 4-methylenedioxymethamphetamine polydrug users. Archives of General Psychiatry 2012, 69:399-409. 10.1001/archgenpsychiatry.2011.156.
17. Dickson C., Bruno R., Brown J. Investigating the role of serotonin in visual orientation processing using an 'ecstasy' (MDMA)-based research model. Neuropsychobiology 2009, 60:204-212. 10.1159/000253556.
18. DiClemente C.C., Carbonari J., Zweben A., Morrel T., Lee R.E. Motivation hypothesis casual chain analysis. Project MATCH: A priori matching hypotheses, results, and mediating mechanisms 2001, Vol. 8:206-222. National Institute on Alcohol Abuse and Alcoholism, Rockville, MD.
19. DiClemente C.C., Schlundt D., Gemmell L. Readiness and stages of change in addiction treatment. American Journal on Addictions 2004, 13:103-119. 10.1080/10550490490435777103.
20. Fals-Stewart W., O'Farrell T.J., Freitas T.T., McFarlin S.K., Rutigliano P. The Timeline Followback reports of psychoactive substance use by drug-abusing patients: Psychometric properties. Journal of Consulting and Clinical Psychology 2000, 68:134-144.
21. Faul F., Erdfelder E., Lang A.G., Buchner A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods 2007, 39:175-191. 10.3758/BF03193146.
22. Field C.A., Adinoff B., Harris T.R., Ball S.A., Carroll K.M. Construct, concurrent and predictive validty of the URICA: Data from two multi-site clinical trials. Drug and Alcohol Dependence 2009, 101:115-123. 10.1016/j.drugalcdep.2008.12.003.
23. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders-Patient Edition (SCID-I/P, 1/2007 revision) 2007, Biometrics Research Department, New York.
24. Fox H.C., Parrott A.C., Turner J.J.D. Ecstasy use: Cognitive deficits related to dosage rather than self-reported problematic use of the drug. Journal of Psychopharmacology 2001, 15:273-281. 10.1177/026988110101500406.
25. Gaume J., Gmel G., Faouzi M., Dappen J.-B. Counselor skill influences outcomes of brief motivational interventions. Journal of Substance Abuse Treatment 2009, 37:151-159.
26. Gibbons C.J., Nich C., Steinberg K., Roffman R.A., Corvino J., Babor T., Carroll K.M. Treatment process, alliance and outcome in brief versus extended treatments for marijuana dependence. Addiction 2010, 105:1799-1808.
27. Gossop M., Best D., Marsden J., Strang J. Test-retest reliability of the Severity of Dependence Scale. Addiction 1997, 92:353. 10.1111/j.1360-0443.1997.tb03205.x.
28. Gossop M., Griffiths P., Powis B., Strang J. Severity of dependence and route of administration of heroin, cocaine, and amphetamines. British Journal of Addiction 1992, 87:527-1536. 10.1111/j.1360-0443.1992.tb02660.x.
29. Hanson K.L., Luciana M. Neurocognitive function in users of MDMA: The importance of clinically significant patterns of use. Psychological Medicine 2004, 34:229-246. 10.1017/S0033291703001132.
30. Huang Y., Tang T., Lin C., Yen C. Effects of motivational enhancement therapy on readiness to change MDMA and methamphetamine use behaviors in Taiwanese adolescents. Substance Use and Misuse 2011, 46:411-416.
31. Kraemer H.C., Mintz J., Noda A., Tinklenberg J., Yesavage J.A. Caution regarding the use of pilot studies to guide power calculations for study proposals. Archives of General Psychiatry 2006, 63:484-489. 10.1001/archpsyc.63.5.484.
32. Kypri K., Langley J.D., Saunders J.B., Cashell-Smith M.L. Assessment may conceal therapeutic benefit: Findings from a randomized controlled trial for hazardous drinking. Addiction 2007, 102:62-70. 10.1111/j.1360-0443.2006.01632.x.
33. Little R.J.A. A test of missing completely at random for multivariate data with missing values. Journal of the American Statistical Society 1988, 83:1198-1202.
34. Longabaugh R., Wirtz P.W., Zywiak W.H., O'malley S.S. Network support as a prognostic indicator of drinking outcomes: The COMBINE study. Journal of Studies on Alcohol and Drugs 2010, 71:837.
35. Lovibond S.H., Lovibond P.F. Manual for the depression anxiety stress scales 1995, Psychology Foundation, Sydney. 2nd ed.
36. Lundahl B.W., Kunz C., Brownell C., Tollefson D., Burke B.L. A meta-analyis of motivational interviewing: Twenty-five years of empirical studies. Research on Social Work Practice 2010, 20:137-160.
37. Marsden J., Stillwell G., Barlow H., Boys A., Taylor C., Hunt N., Farrell M. An evaluation of a brief motivational intervention among young ecstasy and cocaine users: No effect on substance and alcohol use outcomes. Addiction 2006, 101:1014-1026.
38. Martin G., Copeland J. Brief intervention for regular ecstasy (MDMA) users: Pilot randomized trial of a Check-up model. Journal of Substance Use 2010, 15:131-142.
39. Martino S., Ball S.A., Nich C., Frankforter T.L., Carroll K.M. Community program therapist adherence and competence in motivational enhancement therapy. Drug and Alcohol Dependence 2008, 96:37-48.
40. McCambridge J., Bendtsen M., Karlsson N., White I.R., Nilsen P., Bendtsen P. Alcohol assessment and feedback by email for university students: Main findings from a randomised controlled trial. BJPsych 2013, 203:334-340. 10.1192/bjp.bp.113.128660.
41. McCann U.D., Sgambati F.P., Schwartz A.R., Ricaurte G.A. Sleep apnea in young abstinent recreational MDMA (ecstasy) consumers. Neurology 2009, 73:2011-2017. 10.1212/WNL.0b013e3181c51a62.
42. McConnaughy E.A., Prochaska J.O., Velicer W.F. Stages of change in psychotherapy: Measurement and sample profiles. Psychotherapy: Theory, Research and Practice 1983, 20:368-375.
43. McKetin R., Copeland J., Norberg M.M., Bruno R., Hides L., Khawar L. The effect of the ecstasy 'come-down' on the diagnosis of ecstasy dependence. Drug and Alcohol Dependence 2014, 139:26-32.
44. McNally A.M., Palfai T.P., Kahler C.W. Motivational interventions for heavy drinking college students: Examining the role of discrepancy-related psychological processes. Psychology of Addictive Behaviors 2005, 19:79-87.
45. Miller W.R. When is it motivational interviewing?. Addiction 2001, 96:1770-1771.
46. Miller W.R., Moyers T.B., Ernst D., Amrhein P. Manual for the Motivational Interviewing Skill Code (MISC). Center on Alcoholism, Substance Abuse, and Addictions 2008, The University of New Mexico.
47. Miller W.R., Rollnick S. Motivational interviewing: Preparing people for change 2002, Guilford, New York. 2nd ed.
48. Nuro K.F., Maccarelli L., Ball S.A., Martino S., Baker S.M., Rounsaville B.J., Carroll K.M. Yale Adherence and Competence Scale (YACSII) guidelines 2005, Yale University Psychotherapy Development Center, West Haven, CT. 2nd ed.
49. Parrott A.C. Chronic tolerance to recreational MDMA (3, 4-methylenedioxymethamphetamine) or ecstasy. Journal of Psychopharmacology 2005, 19:75-87.
50. Parrott A.C. Cortisol and MDMA (3,4-methylenedioxymethamphetamine): Neurohormonal aspects of bioenergetic-stress in Ecstasy users. Neuropsychobiology 2009, 60:148-158.
51. Parrott A.C. Conscious awareness versus optimistic beliefs in recreational Ecstasy/MDMA users. New horizons in the neuroscience of consciousness. 2010, John Benjamins Publishing Company, Amsterdam. E. Perry, D. Collerton, F. LeBeau, H. Ashton (Eds.).
52. Parrott A.C. MDMA, serotongeric neurotoxicity, and the diverse functional deficits of recreational "Ecstasy" users. Neuroscience and Biobehavioral Reviews 2013, 37:1466-1484. 10.1016/j.neubiorev.2013.04.016.
53. Project MATCH Research Group Matching alcoholishm treatment to client heterogeneity: Project MATCH posttreatment drinking outcomes. Journal of Studies on Alcohol 1997, 58:7-29.
54. Rendell P.G., Gray T.J., Henry J.D., Tolan A. Prospective memory impairment in ecstasy (MDMA) users. Psychopharmacology 2007, 194:497-504. 10.1007/s00213-007-0859-z.
55. Rogers G., Elston J., Garside R., Roome C., Taylor R., Younger P., . . ., Somerville M. The harmful health effects of recreational ecstasy: A systematic review of observational evidence. Health Technology Assessment 2009, 13:1-315. 10.3310/hta13060.
56. Silins E., Bleeker A., Martin G. Ecstasy: Facts and Fiction 2008, National Drug and Alcohol Research Centre, Syndey. 2nd ed.
57. Sindicich N., Burns L. Australian trends in ecstasy and related drug markets 2012. Findings from the Ecstasy and Related Drugs Reporting System (EDRS) 2013, National Drug and Alcohol Research Centre, University of New South Wales, Sydney.
58. Sklar S.M., Turner N.E. A brief measure for the assessment of coping self-efficacy among alcohol and other drug users. Addiction 1999, 94:723-729. 10.1046/j.1360-0443.1999.94572310.x.
59. Sobell L.C., Brown J., Leo G.I., Sobell L.C. The reliability of the Alcohol Timeline Followback when adminsitered by telephone and by computer. Drug and Alcohol Dependence 1996, 42:49-54.
60. Sobell L.C., Sobell M.C. Timeline Followback: A calendar method for assessing alcohol and drug use 1996, Addiction Research Foundation, Toronto, Ontario.
61. Strang J., McCambridge J. Can the practitioner correctly predict outcome in motivational interviewing?. Journal of Substance Abuse Treatment 2004, 27:83-88.
62. Topp L., Hando J., Dillon P., Roche A., Solowij N. Ecstasy use in Australia: Patterns of use and associated harm. Drug and Alcohol Dependence 1999, 55:105-115.
63. United Nations Office on Drugs and Crime World Drug Report 2013 Retrieved from, on 14/FEB/2014. http://www.unodc.org/unodc/secured/wdr/wdr2013/World_Drug_Report_2013.pdf.
64. Verheyden S.L., Henry J.A., Curran G. Acute, sub-acute and long-term subjective consequences of "ecstasy" (MDMA) consumption in 430 regular users. Human Psychopharmacology 2003, 18:507-517. 10.1002/hup.529.
65. Verheyden S.L., Maidment R., Curran H.V. Quitting ecstasy: An investigation of why people stop taking the drug and their subsequent mental health. Journal of Psychopharmacology 2003, 17:371-378. 10.1177/0269881103174014.
66. Wilson K.G., Sandoz E.K., Kitchens J., Roberts M. The Valued Living Questionnaire: Defining and measuring valued action within a behavioral framework. The Psychological Record 2010, 60:249-272.
67. Zanarini M.C., Skodol A.E., Bender D., Dolan R., Sanislow C., Schaefer E., . . ., Gunderson J.G. The Collaborative Longitudinal Personality Disorders Study: Reliability of axis I and II diagnoses. Journal of Personality Disorders 2000, 14:291-299. 10.1521/pedi.2000.14.4.291.